Medication info

Cantonel Plus Tablet

Prescription medicationTabletOral
Ingredient · strength
Risedronate Sodium 2.5 Hydrate›40.162mgCholecalciferol Concentrate Powder›56mg
Manufacturer / importer
Anguk Pharmaceutical Co., Ltd.
Appearance
Light orange oval film-coated tablet
Packaging
4 tablets
Approval status
Active

MFDS item code 201606075 · Approved 2016.10.13

Summary

Main use
Treatment of osteoporosis (in postmenopausal women and men); prevention of osteoporosis in postmenopausal women
Who takes it
Adults · Children
Adult dose
1. Adults: Take 1 tablet orally once weekly. 2. Older adults: No dose adjustment is necessary in older adults (60 years of age or older), because the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment (creatinine clearance below 30 mL/min). Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this medicine. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine provides a week's supply of vitamin D at 800 IU daily when taken once weekly. If a patient forgets to take a dose on the scheduled day, take it on the day the patient remembers. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.
Child dose
3. Children: The safety and efficacy of this medicine have not been established in children or growing adolescents.

Ingredients

Manufacturer
Anguk Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment of osteoporosis (in postmenopausal women and men); prevention of osteoporosis in postmenopausal women

  • Osteoporosis
View approved original text

This medication is used to treat and prevent osteoporosis in both postmenopausal women and men.

How to take

Adult dose

1. Adults: Take 1 tablet orally once weekly. 2. Older adults: No dose adjustment is necessary in older adults (60 years of age or older), because the bioavailability and pharmacokinetics of this medicine are similar to those in younger people. 4. Patients with renal impairment: No dose adjustment is necessary in patients with creatinine clearance of 30 mL/min or greater. This medicine is contraindicated in patients with severe renal impairment (creatinine clearance below 30 mL/min). Because food interferes with the absorption of this medicine, take it as follows to ensure adequate absorption. Take it at least 30 minutes before breakfast, or at any time of day at least 2 hours before or after consuming food or beverages. To facilitate passage of this medicine into the stomach and reduce the possibility of esophageal irritation, take it in an upright position with a sufficient amount of plain water (170 ~ 230ml). Taking it with other beverages, including mineral water, may reduce absorption. Do not chew or suck this medicine because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking this medicine. Patients with inadequate calcium and vitamin D intake from food should take supplements. Patients at high risk of vitamin D deficiency (e.g., patients over 70 years of age, patients in nursing homes, and patients with chronic diseases) may require additional vitamin D supplementation. Patients with gastrointestinal malabsorption syndrome may require higher doses of vitamin D supplements, and measurement of 25-hydroxyvitamin D levels should be considered. The recommended daily intake of vitamin D is 400 IU to 800 IU. This medicine provides a week's supply of vitamin D at 800 IU daily when taken once weekly. If a patient forgets to take a dose on the scheduled day, take it on the day the patient remembers. Take the next dose again on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

3. Children: The safety and efficacy of this medicine have not been established in children or growing adolescents.

Precautions

This medication can irritate the mucous membranes of the stomach and esophagus, which may result in esophagitis, esophageal ulcers, or esophageal erosion. Patients with esophageal diseases such as esophageal stricture or achalasia, patients with hypocalcemia, patients with severe renal impairment, and patients who cannot remain upright for 30 minutes after taking this medication should not take it. It should be taken with a sufficient amount of water, and patients should remain upright for at least 30 minutes after taking it. If any symptoms of esophageal irritation occur, discontinue use immediately and consult a doctor. This medication may be required for supplementation if there is inadequate intake of calcium and vitamin D, especially in patients undergoing long-term steroid therapy. As a bisphosphonate, serious side effects such as osteonecrosis of the jaw, skin allergic reactions, and severe gastrointestinal bleeding may occur rarely; notify medical staff immediately if any unusual symptoms arise. Women who are pregnant or breastfeeding must consult a doctor before taking this medication, and safety in children has not been established. When taking this medication, it may interfere with the absorption of other medications or foods containing calcium, magnesium, iron, etc., so a time interval should be maintained. Overdose may lead to hypocalcemia, which would require appropriate treatment and medical supervision. This medication should be stored out of reach of children, and it is important not to transfer it to other containers during storage.

Side effects

  • Esophagitis
  • esophageal ulcer
  • esophageal erosion
  • esophageal obstruction
  • esophageal perforation
  • hemorrhage
  • gastric ulcer
  • duodenitis
  • stomatitis
  • decreased serum calcium
Show 85 more
  • decreased serum phosphorus
  • bone pain
  • joint pain
  • muscle pain
  • leg cramps
  • bursitis
  • tendon abnormality
  • depression
  • dizziness
  • insomnia
  • anxiety
  • neuralgia
  • vertigo
  • hypertonia
  • sensory abnormalities
  • pharyngitis
  • rhinitis
  • dyspnea
  • pneumonia
  • rash
  • pruritus
  • skin cancer
  • cataract
  • conjunctivitis
  • otitis media
  • urinary tract infection
  • cystitis
  • injury due to accident
  • epidemic cold syndrome
  • headache
  • overdose
  • allergic reaction
  • syncope
  • vasodilation
  • constipation
  • indigestion
  • nausea
  • diarrhea
  • gastroenteritis
  • bloating
  • colitis
  • vomiting
  • thirst
  • peripheral edema
  • traumatic fracture
  • myalgia
  • arthritis
  • bronchitis
  • sinusitis
  • increased cough
  • fever
  • falling
  • dizziness
  • bronchitis
  • cough
  • edema
  • facial swelling
  • alopecia
  • altered sense of smell
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • angioedema
  • blister
  • jawbone necrosis
  • liver function impairment
  • jaundice
  • external ear bone necrosis
  • anorexia
  • asthenia
  • heartburn
  • epigastric pain
  • chest discomfort
  • palpitations
  • increased sweating
  • facial flushing
  • burning sensation
  • kidney stones
  • belching
  • hematuria
  • fever
  • fatty liver
  • increased serum alkaline phosphatase
  • facial swelling
  • uveitis
  • iritis

Not everyone experiences these, and they can vary from person to person.

Storage

This medication should be stored in a tightly sealed container to avoid exposure to air or moisture. It is important to maintain a storage temperature between 1 degree and 30 degrees Celsius at room temperature. This will help maintain the drug's efficacy and safety.

Appearance and packaging

Appearance

Light orange oval film-coated tablet

Package unit

4 tablets

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.